Typ 2 diabetes
Artiklar
Recognizing the Urgency to proactively plan a switch: Managing Timely Insulin Transitions for Continuity of Care
Learn why timely insulin transitions are critical for patient safety and continuity of care. Act early to avoid gaps and risks.
Psychological Considerations During Insulin Product Changes
Understanding the psychological burden of switching insulin. Discover ways to cope and support patient well-being during treatment changes.
Diabetes och Ramadan
2026 infaller Ramadan mellan 17 februari och 19 mars. Vi har tagit fram material för att hjälpa dig att stötta din patient med diabetes som vill fasta under Ramadan.
Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk
People with type 2 diabetes and atherosclerotic cardiovascular disease face a high risk of cardiovascular events, yet many remain undertreated.1 The EASD/ADA 2022 and ESC 2023 guidelines for the management of type 2 diabetes urge early insulin initiation and intensive lipid lowering through a holistic approach. Managing both glycemia and lipids together is key to preventing CV events in people with type 2 diabetes.2,3
Pooled analysis: Interventional and observational studies
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy.1
Utbildning
Personalized approach in T2D is key for success
The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.
.svg)
SE-FILMEN-HÄR
